Zydus Lifesciences Moraiya facility gets EIR from USFDA
The inspection was a PAI for Transdermal Patch products
Ahmedabad: Zydus Lifesciences Limited has announced that the company has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for the inspection conducted at its manufacturing facility located at Moraiya, Ahmedabad.
The inspection was conducted from 23rd to 27th January 2023.
The inspection was a PAI for Transdermal Patch products. The Audit had ended with NIL observations.
Read also: Zydus Lifesciences gets zero USFDA observations for Moraiya facility
Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited), an Indian Pharmaceutical company is a fully integrated, global healthcare provider. The company was founded in the year 1952 by Mr. Ramanbhai B. Patel (late), a first-generation entrepreneur and a doyen in the field of Indian Pharmaceuticals.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd